Trexquant Investment LP Haemonetics Corp Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$80.84 - $89.45 $2.42 Million - $2.68 Million	-29,949 Reduced 67.75%	14,258 $1.21 Million
Q1 2023 May 15, 2023	SELL	$72.75 - $90.6 $1.52 Million - $1.89 Million	-20,894 Reduced 32.09%	44,207 $3.66 Million
Q4 2022 Feb 13, 2023	BUY	$73.85 - $86.14 $3.74 Million - $4.37 Million	50,705 Added 352.22%	65,101 $5.12 Million
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $7.09 Million - $8.81 Million	-112,043 Reduced 88.61%	14,396 $1.07 Million
Q2 2022 Aug 11, 2022	BUY	$49.27 - $66.08 $6.06 Million - $8.13 Million	123,026 Added 3604.63%	126,439 $8.24 Million
Q1 2022 May 13, 2022	SELL	$43.77 - $63.22 $195,039 - $281,708	-4,456 Reduced 56.63%	3,413 $216,000
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $389,908 - $586,948	7,869 New	7,869 $417,000
Q1 2021 May 13, 2021	SELL	$111.01 - $139.48 $325,037 - $408,397	-2,928 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$88.75 - $119.95 $171,198 - $231,383	-1,929 Reduced 39.72%	2,928 $348,000
Q3 2020 Nov 06, 2020	BUY	$75.65 - $93.58 $367,432 - $454,518	4,857 New	4,857 $424,000
Q1 2020 May 08, 2020	SELL	$74.34 - $121.82 $477,039 - $781,718	-6,417 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$114.37 - $129.46 $126,836 - $143,571	-1,109 Reduced 14.74%	6,417 $737,000
Q3 2019 Nov 08, 2019	BUY	$117.16 - $138.52 $881,746 - $1.04 Million	7,526 New	7,526 $949,000
Q2 2019 Aug 09, 2019	SELL	$81.74 - $120.34 $988,481 - $1.46 Million	-12,093 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$83.25 - $102.12 $1.01 Million - $1.23 Million	12,093 New	12,093 $1.06 Million
Q4 2018 Feb 13, 2019	SELL	$90.66 - $116.63 $188,572 - $242,590	-2,080 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$89.96 - $114.58 $3.08 Million - $3.93 Million	-34,285 Reduced 94.28%	2,080 $238,000
Q2 2018 Aug 07, 2018	BUY	$71.53 - $95.75 $1.27 Million - $1.7 Million	17,756 Added 95.42%	36,365 $3.26 Million
Q1 2018 May 03, 2018	BUY	$60.72 - $74.41 $1.13 Million - $1.38 Million	18,609 New	18,609 $1.36 Million
Q4 2017 Feb 09, 2018	SELL	$44.96 - $58.99 $463,177 - $607,714	-10,302 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$40.38 - $44.87 $415,994 - $462,250	10,302	10,302 $462,000

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$506 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$439 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$377 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$357 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$342 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.36B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account